Trials / Completed
CompletedNCT04741009
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
A Pre-market, Open-label Feasibility, Prospective, Single-arm Multicenter Feasibility Investigation of Hearing Performance Using the CI632 in Adults With Low-frequency Residual Hearing.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Cochlear · Industry
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CI632 Slim Modiolar Electrode | Cochlear Ltd CI632 cochlear implant with Slim Modiolar Electrode |
Timeline
- Start date
- 2021-12-16
- Primary completion
- 2025-06-16
- Completion
- 2025-06-16
- First posted
- 2021-02-05
- Last updated
- 2025-07-18
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04741009. Inclusion in this directory is not an endorsement.